China Medical System (867.HK, 8A8.SG) NDA for the Improved New Drug ZUNVEYL for Alzheimer's Disease Accepted in China Jul 29, 2025 04:00 HKT |  |
|
亿胜生物多剂量地夸磷索钠滴眼液获中国国家药品监督管理局批准上市 Jul 25, 2025 10:52 HKT |  |
|
億勝生物多劑量地誇磷索鈉滴眼液獲中國國家藥品監督管理局批准上市 Jul 25, 2025 10:52 HKT |  |
|
Multi-Dose Diquafosol Sodium Eye Drops Obtained Approval from NMPA for Commercialisation in China Jul 25, 2025 10:52 HKT |  |
|
冠科生物圣地亚哥实验室获 CLIA 认证 增强临床试验支持能力 Jul 23, 2025 09:00 HKT |  |
|
冠科生物聖地牙哥實驗室獲 CLIA 認證 增強臨床試驗支援能力 Jul 23, 2025 09:00 HKT |  |
|
CMS Collaborates with SGX to Explore New Paradigms for Industrial Globalization and Pharmaceutical Expansion Overseas across Emerging Markets Jul 22, 2025 13:00 HKT |  |
|
康哲药业携手新交所 共话新兴市场产业国际化与医药出海新范式探索 Jul 18, 2025 13:00 HKT |  |
|
耀啟新程!康哲藥業今日於新加坡交易所主板實現二次上市 Jul 15, 2025 17:05 HKT |  |
|
耀启新程!康哲药业今日于新加坡交易所主板实现二次上市 Jul 15, 2025 16:53 HKT |  |
|
Silo Pharma Enters Letter of Intent for JV with Hoth Therapeutics to Develop Obesity Treatment Targeting $16 Billion Global Market
Jun 25, 2025 21:27 HKT |  |
|
康哲藥業建議於新加坡交易所第二上市 Jun 25, 2025 18:13 HKT |  |
|
康哲药业建议于新加坡交易所第二上市 Jun 25, 2025 17:24 HKT |  |
|
康希諾重磅推出優佩欣疫苗 為兒童健康保駕護航的創新之選 Jun 21, 2025 12:09 HKT | |
|
康希诺重磅推出优佩欣疫苗 为儿童健康保驾护航的创新之选 Jun 20, 2025 17:58 HKT | |
|
Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited May 14, 2025 15:00 HKT |  |
|
HighTide Therapeutics to Showcase New Analyses of Phase 2 MASH/T2DM Studies of Berberine Ursodeoxycholate (HTD1801) and Pre-Clinical Results of Rimtoregtide (HTD4010) in Presentations at EASL Congress 2025 Apr 24, 2025 18:43 HKT |  |
|
君圣泰医药三项创新研究成果即将亮相2025欧肝会(EASL) Apr 24, 2025 18:35 HKT |  |
|
熊去氧胆小檗碱(HTD1801)一药多效 即将进入商业化新纪元 Apr 15, 2025 08:10 HKT |  |
|
熊去氧膽小檗堿(HTD1801)一藥多效 即將進入商業化新紀元 Apr 15, 2025 08:10 HKT |  |
|
Next >>
|